- Access is usually transperitoneal via a midline laparotomy, which is quick and gives good exposure
- A left retroperitoneal (flank) approach is an alternative, often reserved for a hostile abdomen or complex aneurysms
- Heparin is given, and the aorta is cross-clamped above the aneurysm and the iliac arteries clamped below
- The clamp is usually infra-renal, but juxta- and supra-renal aneurysms need a supra-renal or supra-coeliac clamp, with much greater physiological consequences
- Clamping can embolise atheromatous plaque
- The sac is opened, back-bleeding lumbar arteries are oversewn and the graft is sutured to the aorta at each end
- Grafts may be straight 'tubes' or bifurcated 'trousers'
- Flow to at least one internal iliac artery is preserved to reduce the risk of buttock claudication and colonic ischaemia
- The sac is closed over the graft to separate it from the bowel
Elective Open AAA Repair
Elective Open AAA Repair
The curriculum asks for knowledge of the "Perioperative management of the patient for open major vascular surgery eg abdominal aneurysm repair".
The physiology of the cross-clamp, including renal protection, is covered on the aortic cross-clamp physiology page, and emergency open repair on the ruptured AAA page.
Resources
- Anaesthesia for elective open abdominal aortic aneurysm repair (BJA Education, 2013)
- European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms (European Journal of Vascular and Endovascular Surgery, 2024)
- Abdominal aortic aneurysm: diagnosis and management (NICE, 2020)
- Anaesthesia for endovascular aortic aneurysm repair (WFSA, 2014)
- The aim of AAA repair, be it open or via EVAR, is to exclude the weak, aneurysmal segment from the circulation using a synthetic graft
- Open repair is generally offered to younger, fitter patients with a long life expectancy, or those whose anatomy is unsuitable for EVAR
- The main goal is to stratify and minimise the risk of a high-risk procedure, and to inform shared decision-making in the vascular MDT
History and examination
- Coronary artery disease is the leading cause of morbidity and mortality after AAA repair; 70% of patients undergoing repair have it
- Other common comorbidities increasing risk include cerebrovascular disease, renal impairment, COPD and diabetes
- Functional capacity (e.g. METs) and frailty; frailty is associated with a five-fold increase in 30-day mortality after AAA repair
- Medication review, particularly antiplatelets and anticoagulants
Investigations
- Bloods: FBC | U&E and eGFR | Clotting | Albumin | Group and cross-match (6 units in our local vascular centre)
- ECG
- Transthoracic echo.
- Objective functional assessment e.g. CPET
- The VASGBI recommend objective assessment of functional capacity, with CPET where available, and it is widely used in UK practice
- By contrast, the ESVS (2024) advise against routine CPET, coronary angiography or revascularisation in stable coronary disease, and against routine spirometry or CXR
- The ESVS do recommend that patients with poor functional capacity (<4 METs) or active cardiac conditions (e.g. unstable angina, decompensated heart failure, severe valvular disease, significant arrhythmia) need cardiology work-up and optimisation
- Carotid imaging only if there are symptoms of carotid disease; a recently symptomatic 50 - 99% stenosis should be treated first
- CT angiography for surgical planning
Risk assessment
- A number of risk prediction tools are available e.g. the Glasgow Aneurysm Score, V-POSSUM, the British Aneurysm Repair score and Carlisle's calculator (he has a word or two to say about risk prediction models)
- NICE (2020) recommend using... none of them, owing to a lack of "high enough predictive accuracy at predicting postoperative outcomes"
- Patients could be stratified by predicted operative mortality into low (1 - 3%), moderate (3 - 5%) and high (5 - 10%) risk groups
Optimisation
- Smoking cessation; this reduces respiratory complications and 1-year mortality after both open repair and EVAR
- Start a statin, ideally at least 4 weeks before surgery, and continue it indefinitely
- Continue aspirin (or clopidogrel) monotherapy; dual antiplatelet therapy and oral anticoagulants should be avoided peri-operatively where possible, which may involve liaison with Cardiology
- Continue β-blockers if already taking, but do not start them pre-operatively
- Control blood pressure
- Treat anaemia
- Optimise COPD to reduce the risk of post-operative pulmonary complications
- Correct malnutrition; the ESVS use an albumin <28g/L as a threshold for pre-operative correction
- Prehabilitation may modestly reduce cardiac and renal complications, though the evidence is of low certainty
Monitoring and access
- AAGBI monitoring, with 5-lead ECG or the CM5 configuration as they are more sensitive for detecting myocardial ischaemia
- Arterial line and central line
- Large-bore IV access, with a rapid infuser and warmer available
- Temperature monitoring and active warming; normothermia aids haemostasis, although lower body warming should be avoided while the clamp is on
- Urinary catheter
- Cardiac output monitoring e.g. oesophageal doppler may be unreliable while the aorta is clamped, and pulse contour analysis is not fully validated in this setting
Anaesthetic technique
- A thoracic epidural is commonly sited before induction for intra- and post-operative analgesia
- It is often not loaded until after clamp release and haemostasis, as sympathetic blockade may worsen declamping hypotension
- Rectus sheath or wound catheters are an alternative; the ESVS rate both options equally
- Induction and maintenance are as per routine practice; propofol/remifentanil TCI with pEEG monitoring is preferred in my trust
- Prophylactic antibiotics
- Communicate with the surgeons ahead of both clamp application and release; typical targets are:
- Systolic BP ~100mmHg immediately before clamp application, in anticipation of the hypertension that follows
- Systolic BP ~130mmHg immediately before clamp release, in anticipation of declamping hypotension
- The management of each phase is covered on the aortic cross-clamp physiology page
Clotting, bleeding and fluid therapy
- IV heparin (50 - 100 IU/kg; e.g. 5,000 IU for the fictional 70kg patient) is given before clamping to prevent thrombosis from stasis distal to the clamp
- Targeting an ACT of 2 - 2.5× baseline ± protamine reversal is described, although this is not current practice in my institution
- Cell salvage should be used
- As these patients have significant cardiovascular disease, a transfusion threshold of ~80g/L is reasonable
- Other blood products should be guided by viscoelastic haemostatic assays
- Fluid loading before clamp release helps reduce declamping hypotension; this can be titrated to stroke volume or CVP
Intra-operative complications
- The big worry is myocardial ischaemia or infarction
- Acute LV failure and arrhythmias
- Major haemorrhage
- Distal embolism and limb ischaemia
- All patients should go to a critical care (HDU or ICU) setting
- Analgesia via the thoracic epidural or rectus sheath catheters, plus simple analgesics and opioids as needed
- Regular lower limb neurovascular observations
- An ERAS-style approach of early feeding, mobilisation, physiotherapy and VTE prophylaxis
- Continue statin, antiplatelet and antihypertensive therapy lifelong
Post-operative complications
- Cardiac: myocardial infarction, heart failure and arrhythmias
- Respiratory: atelectasis, pneumonia and respiratory failure
- Renal: AKI
- Gastrointestinal: ileus and colonic ischaemia
- Bleeding, graft thrombosis and limb ischaemia
- If clamping was supra-coeliac; hepatic dysfunction and spinal cord ischaemia
- Late: incisional hernia, graft infection and sexual dysfunction
- A European Society for Vascular Surgery report (2008) showed the UK mortality rate after open AAA repair was the highest in Europe and Australasia (7.9% vs. 3.5%)
- The AAA Quality Improvement Programme (AAA-QIP) was developed in response, alongside centralisation of vascular services
- Mortality has fallen significantly as a result; overall elective AAA repair mortality was 2.4% in 2012
Previous: EVAR | Next: Ruptured AAA